ZimVie Announces Publication of a Study Supporting the Benefits of Its Implant Surface Technologies

Core Insights - ZimVie Inc. has published a scientific study indicating that its premium dental implants may reduce the risk of peri-implant infections compared to other implants available in the market [1][2][3] Group 1: Study Findings - The study, published in the Journal of Biomedical Materials Research, evaluated ZimVie's dual acid-etched coronal surface technology against other leading implant brands [2] - The research highlights a critical threshold roughness for implant surfaces, where rougher surfaces increase bacterial adhesion, while ZimVie's implants maintain adhesion levels comparable to smooth machined surfaces [3] - ZimVie's Contemporary Hybrid Surface technologies are designed to mitigate the rising prevalence of peri-implant mucositis and peri-implantitis [3] Group 2: Product Information - TSX Implants, launched in 2022, are engineered for immediate extraction and standard loading protocols, focusing on primary stability and crestal bone maintenance [4] - T3 PRO Implants, also launched in 2022, feature a hybrid surface design that promotes high primary stability and immediate function, with clinical studies supporting their safety and performance [5] Group 3: Company Overview - ZimVie is a global leader in the dental market, dedicated to developing and delivering a comprehensive range of products for dental tooth replacement and restoration [7] - The company operates from its headquarters in Palm Beach Gardens, Florida, and aims to enhance patient outcomes through advanced clinical science and technology [7]